Why Physician-Led Healthcare Platforms Outperform PE Rollups Over Time
Physician-led platforms outperform PE rollups over a ten-year horizon for three structural reasons: clinical decisions stay with people whose career depends on them, physician retention is materially higher when partners hold platform-level equity, and the patient experience is governed by the clinical standard rather than by the EBITDA target. The trade-off is slower scaling and a smaller fee pool — by design.
A decade of healthcare-services consolidation has produced a clear empirical pattern. The platforms with the deepest physician disengagement, the highest mid-tenure attrition, and the most public quality-of-care complaints share one structural feature: they were assembled and governed by financial sponsors, not by the physicians inside them. The platforms that remain stable through cycle after cycle — the academic medical centers, the physician-owned multi-specialty groups, the few founder-physician aesthetic platforms that survived their second turn of capital — share the opposite structural feature.
ZMD Group is being built deliberately on that side of the line. Our partnership framework is structured so that clinical authority cannot be diluted by an absentee parent and so that physicians who join the platform receive equity at the platform level, not just at the practice level. The goal is not to be the fastest-scaling multi-specialty group in the country. The goal is to be the one a serious physician would still want to be inside ten years from now.
Written for ZMD Group Editorial. Inquiries: [email protected].